SynthesisWorld journal of surgical oncology2025
The effectiveness of adjuvant radiotherapy after thymoma resection: a systematic review and meta-analysis.
Synthesis in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionOur systematic review and meta-analysis aimed to investigate the impact of postoperative radiotherapy(PORT) on patient outcomes following thymoma resection.
methodsA comprehensive search of PubMed, EMbase, The Cochrane Library, Web of Science, Wanfang, Wipo, and China Knowledge Network databases was systematically conducted. Relevant literature comparing the therapeutic efficacy and effectiveness of thymectomy and thymectomy+ PORT in patients with thymoma published until August 2024 was gathered. The retrospective studies included in this analysis were evaluated using the Newcastle-Ottawa Scale (NOS), while meta-analysis of the literature was performed using Review Manager 5.4 software.
resultsA total of 23 retrospective studies, encompassing 13,742 patients, were included in the analysis. Among them, 6,980 patients belonged to the surgery-only group (3,321 male patients and 3,659 female patients), with an average age of 54.08 years. The surgery + PORT group consisted of 6,762 patients (3,385 male patients and 3,377 female patients) with an average age of 53.76 years. All included studies had a NOS score of ≥7.The meta-analysis results revealed that, in comparison to the surgery group, the surgery + PORT group exhibited higher rates of overall survival at 1 year, 3 years, 5 years, and 10 years. Additionally, the surgery + PORT group demonstrated superior disease-free survival (DFS)rates at 1 year and 5 years as well as disease-specific survival (DSS) rates at 3 years, 5 years, and 10 years. However, no significant differences were observed between the two groups in terms of DFS at 3 years or DSS at 1 year.
conclusionsAvailable retrospective evidence indicates an association between PORT and improved survival after thymoma resection, though prospective validation is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.